BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9413952)

  • 1. PK Modeling of L-4-Boronophenylalanine and Development of Bayesian Predictive Platform for L-4-Boronophenylalanine PKs for Boron Neutron Capture Therapy.
    Kim W; Won JY; Yi J; Choi SC; Lee SM; Mun K; Lim HS
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic assessment of
    Lin KH; Chen YW; Wang LW; Wang YF; Hu LH; Ting CH; Lee TH; Lee JC; Peng NJ
    Quant Imaging Med Surg; 2024 Jun; 14(6):4177-4188. PubMed ID: 38846276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary study of the relative and compound biological effectiveness model for boron neutron capture therapy based on nanodosimetry.
    Mao H; Zhang H; Luo Y; Yang J; Liu Y; Zhang S; Chen W; Li Q; Dai Z
    Med Phys; 2024 Apr; 51(4):3076-3092. PubMed ID: 38408025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boronated Condensed DNA as a Heterochromatic Radiation Target Model.
    Perry CC; Ramos-Méndez J; Milligan JR
    Biomacromolecules; 2021 Apr; 22(4):1675-1684. PubMed ID: 33750108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy.
    Tokura D; Konarita K; Suzuki M; Ogata K; Honda Y; Miura Y; Nishiyama N; Nomoto T
    J Control Release; 2024 Jun; 371():445-454. PubMed ID: 38844180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors.
    Fujikawa Y; Kawabata S; Tsujino K; Yamada H; Kashiwagi H; Yagi R; Hiramatsu R; Nonoguchi N; Takami T; Sasaki A; Hu N; Takata T; Tanaka H; Suzuki M; Wanibuchi M
    Cancer Sci; 2024 Jun; ():. PubMed ID: 38860412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-damage RBE assessment for combined boron and gadolinium neutron capture therapy.
    Shamsabadi R; Baghani HR
    J Appl Clin Med Phys; 2024 May; ():e14399. PubMed ID: 38767333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of atmospheric neutrons.
    Voyant C; Roustit R; Tatje J; Biffi K; Leschi D; Briançon J; Marcovici CL
    Rep Pract Oncol Radiother; 2011 Jan; 16(1):21-31. PubMed ID: 24669300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational research of boron neutron capture therapy for spinal cord gliomas using rat model.
    Kayama R; Tsujino K; Kawabata S; Fujikawa Y; Kashiwagi H; Fukuo Y; Hiramatsu R; Takata T; Tanaka H; Suzuki M; Hu N; Miyatake SI; Takami T; Wanibuchi M
    Sci Rep; 2024 Apr; 14(1):8265. PubMed ID: 38594281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated Monte Carlo Model for Heterogeneous Glioblastoma Treated with Boron Neutron Capture Therapy.
    Moghaddasi L; Bezak E
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a filtration system to improve the dose distribution of an accelerator-based neutron capture therapy system.
    Hu N; Tanaka H; Ono K
    Med Phys; 2022 Oct; 49(10):6609-6621. PubMed ID: 35941788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with
    Fukuda H
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron Neutron Capture Therapy for High-Grade Skull-Base Meningioma.
    Takeuchi K; Kawabata S; Hiramatsu R; Matsushita Y; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake SI; Kuroiwa T
    J Neurol Surg B Skull Base; 2018 Oct; 79(Suppl 4):S322-S327. PubMed ID: 30210985
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an integrated Monte Carlo model for glioblastoma multiforme treated with boron neutron capture therapy.
    Moghaddasi L; Bezak E
    Sci Rep; 2017 Aug; 7(1):7069. PubMed ID: 28765533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
    Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
    BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the structure of the compound biological effectiveness factor.
    Ono K
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i83-i89. PubMed ID: 27021218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
    Morris GM; Coderre JA; Micca PL; Fisher CD; Capala J; Hopewell JW
    Br J Cancer; 1997; 76(12):1623-9. PubMed ID: 9413952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.
    Morris GM; Micca PL; Nawrocky MM; Weissfloch LE; Coderre JA
    Radiat Res; 2002 Dec; 158(6):743-52. PubMed ID: 12452777
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.